Cardiac response to nitric oxide synthase inhibition using aminoguanidine in a rat model of endotoxemia

Shock

Volumn 17, Issue 5, 2002, Pages 404-410

  Vona Davis, Linda ^a   Wearden, Peter ^a   Hill, Jeffrey ^a   Hill, Ronald ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aminoguanidine; Cardiac contractility; Endotoxin; Inducible nitric oxide synthase; Myocytes; Nitrotyrosine; Rat

Indexed keywords

AMINOGUANIDINE; ENDOTOXIN; ENZYME INHIBITOR; GUANIDINE DERIVATIVE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRATE; NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, RAT; TYROSINE;

ANIMAL; ARTICLE; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; ENDOTOXEMIA; HEART; HEART MUSCLE CELL; IN VITRO STUDY; MALE; METABOLISM; PATHOPHYSIOLOGY; PERFUSION; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; DISEASE MODELS, ANIMAL; ENDOTOXEMIA; ENDOTOXINS; ENZYME INHIBITORS; GUANIDINES; HEART; MALE; MYOCYTES, CARDIAC; NITRATES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PERFUSION; RATS; RATS, SPRAGUE-DAWLEY; TYROSINE;

EID: 0036579769     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200205000-00011     Document Type: Article

References (49)

1. Johnson ML, Billiar TR: Roles of nitric oxide in surgical infection and sepsis. World J Surg 22(2): 187-196, 1998.
2. Brady AJ, Poole-Wilson PA, Harding SE, Warren JB: Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol 263(6 Pt 2):H1963-H1966, 1992.
3. Wright CE, Rees DD, Moncada S: Protective and pathological roles of nitric oxide in endotoxin shock [See Comments]. Cardiovasc Res 26(1):48-57, 1992.
4. Schulz R, Panas DL, Catena R, Moncada S, Olley PM, Lopaschuk GD: The role of nitric oxide in cardiac depression induced by interleukin-1 beta and tumour necrosis factor-alpha. Br J Pharmacol 114(1):27-34, 1995.
5. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL: Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257(5068):387-389, 1992.
6. Balligand JL, Ungureanu D, Kelly RA, Kobzik L, Pimentai D, Michel T, Smith TW: Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest 91(5):2314-2319, 1993.
7. Petros A, Lamb G, Leone A, Moncada S, Bennett D, Vallance P: Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 28(1):34-39, 1994.
8. Cobb JP, Natanson C, Hoffman WD, Lodato RF, Banks S, Koev CA, Solomon MA, Elin RJ, Hosseini JM, Danner RL: N Omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J Exp Med 176(4):1175-1182, 1992.
9. Klabunde RE, Ritger RC: NG-monomethyl-L-arginine (NMA) restores arterial blood pressure but reduces cardiac output in a canine model of endotoxic shock. Biochem Biophys Res Commun 178(3):1136-1140, 1991.
10. Avontuur JA, Bruining HA, Ince C: Inhibition of nitric oxide synthesis causes myocardial ischemia in endotoxemic rats. Circ Res 76(3):418-425, 1995.
11. Brady AJ, Warren JB, Poole-Wilson PA, Williams TJ, Harding SE: Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol 265(1 Pt 2):H176-H182, 1993.
12. Szabo C, Southan GJ, Thiemermann C: Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 91(26):12472-12476, 1994.
13. Corbett JA, McDaniel ML: Selective inhibition of inducible nitric oxide synthase by aminoguanidine. Methods Enzymol 268:398-408, 1996.
14. Griffiths MJ, Messent M, MacAllister RJ, Evans TW: Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br J Pharmacol 110(3):963-968, 1993.
15. Misko TP, Moore WM, Kasten TP, Nickols GA, Corbett JA, Tilton RG, McDaniel ML, Williamson JR, Currie MG: Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol 233(1):119-125, 1993.
16. Scott JA, Machoun M, McCormack DG: Inducible nitric oxide synthase and vascular reactivity in rat thoracic aorta: effect of aminoguanidine. J Appl Physiol 80(1):271-277, 1996.
17. Keller RS, Jones JJ, Kim KF, Myers PR, Adams HR, Parker JL, Rubin LJ: Endotoxin-induced myocardial dysfunction: is there a role for nitric oxide? Shock 4(5):338-344, 1995.
18. Meng X, Ao L, Brown JM, Fullerton DA, Banerjee A, Harken AH: Nitric oxide synthase is not involved in cardiac contractile dysfunction in a rat model of endotoxemia without shock. Shock 7(2):111-118, 1997.
19. McDonough KH, Smith T, Patel K, Quinn M: Myocardial dysfunction in the septic rat heart: role of nitric oxide. Shock 10(5):371-376, 1998.
20. Wolfard A, Kaszaki J, Szabo C, Szalay L, Nagy S, Boros M: Prevention of early myocardial depression in hyperdynamic endotoxemia in dogs. Shock 13(1):46-51, 2001.
21. Beckman JS, Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271(5 Pt 1):C1424-C1437, 1996.
22. Schulz R, Dodge KL, Lopaschuk GD, Clanachan AS: Peroxynitrite impairs cardiac contractile function by decreasing cardiac efficiency. Am J Physiol 272(3 Pt 2):H1212-H1219, 1997.
23. Szabo C, Salzman AL, Ischiropoulos H: Peroxynitrite-mediated oxidation of dihydrorhodamine 123 occurs in early stages of endotoxic and hemorrhagic shock and ischemia-reperfusion injury. FEBS Lett 372(2-3):229-232, 1995.
24. Wu CC, Ruetten H, Thiemermann C: Comparison of the effects of aminoguanidine and N-omega-nitro-L-arginine methyl ester on the multiple organ dysfunction caused by endotoxaemia in the rat. Eur J Pharmacol 300(1-2):99-104, 1996.
25. Mikawa K, Nishina K, Tamada M, Takao Y, Maekawa N, Obara H: Aminoguanidine attenuates endotoxin-induced acute lung injury in rabbits. Crit Care Med 26(5):905-911, 1998.
26. Harding SE, Vescovo G, Kirby M, Jones SM, Gurden J, Poole-Wilson PA: Contractile responses of isolated adult rat and rabbit cardiac myocytes to isopro-terenol and calcium. J Mol Cell Cardiol 20(7):635-647, 1988.
27. Takahashi M, Fukuda K, Ohata T, Sugimura T, Wakabayashi K: Increased expression of inducible and endothelial constitutive nitric oxide synthases in rat colon tumors induced by azoxymethane. Cancer Res 57(7):1233-1237, 1997.
28. Wildhirt SM, Schulze C, Conrad N, Kornberg A, Horstman D, Reichart B: Aminoguanidine inhibits inducible NOS and reverses cardiac dysfunction late after ischemia and reperfusion: implications for iNOS-mediated myocardial stunning. Thorac Cardiovasc Surg 47(3):1137-1143, 1999.
29. Scott JA, McCormack DG: Selective in vivo inhibition of inducible nitric oxide synthase in a rat model of sepsis. J Appl Physiol 86(5):1739-1744, 1999.
30. Klabunde RE, Coston AF: Nitric oxide synthase inhibition does not prevent cardiac depression in endotoxic shock. Shock 3(1):73-78, 1995.
31. Liu SF, Adcock IM, Old RW, Barnes PJ, Evans TW: Differential regulation of the constitutive and inducible nitric oxide synthase mRNA by lipopolysaccharide treatment in vivo in the rat. Crit Care Med 24(7):1219-1225, 1996.
32. Kelly RA, Balligand JL, Smith TW: Nitric oxide and cardiac function. Circ Res 79(3):363-380, 1996.
33. Afulukwe IF, Cohen RI, Zeballos GA, Iqbal M, Scharf SM: Selective NOS inhibition restores myocardial contractility in endotoxemic rats, however, myocardial NO content does not correlate with myocardial dysfunction. Am J Respir Crit Care Med 162(1):21-26, 2000.
34. Groeneveld AB, van Lambalgen AA, van den Bos GC, Bronsveld W, Nauta JJ, Thijs LG: Maldistribution of heterogeneous coronary blood flow during canine endotoxin shock. Cardiovasc Res 25(1):80-88, 1991.
35. 2 extraction capabilities during endotoxic shock. J Appl Physiol 83(4):1164-1173, 1997.
36. Tao S, McKenna TM: In vitro endotoxin exposure induces contractile dysfunction in adult rat cardiac myocytes. Am J Physiol 267(5 Pt 2):H1745-H1752, 1994.
37. Panas D, Khadour FH, Szabo C, Schulz R: Proinflammatory cytokines depress cardiac efficiency by a nitric oxide-dependent mechanism. Am J Physiol 275(3 Pt 2):H1016-H1023, 1998.
38. Luss H, Watkins SC, Freeswick PD, Imro AK, Nussler AK, Billiar TR, Simmons RL, del Nido PJ, McGowan FX Jr: Characterization of inducible nitric oxide synthase expression in endotoxemic rat cardiac myocytes in vivo and following cytokine exposure in vitro. J Mol Cell Cardiol 27(9):2015-2029, 1995.
39. Balligand JL, Ungureanu-Longroi D, Simmons WW, Pimental D, Malinski TA, Kapturczak M, Taha Z, Lowenstein CJ, Davidoff AJ, Kelly RA: Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes: characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro. J Biol Chem 269(44):27580-27588, 1994.
40. Edelstein D, Brownlee M: Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. Diabetes 41(1):26-29, 1992.
41. (2+)-independent nitric oxide synthase in the myocardium. Br J Pharmacol 105(3):575-580, 1992.
42. Hock CE, Yin K, Yue G, Wong PY: Effects of inhibition of nitric oxide synthase by aminoguandine in acute endotoxemia. Am J Physiol 272(2 Pt 2):H843-H850, 1997.
43. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie QW, Sokol K, Hutchinson N: Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase [Published Erratum appears in Cell 81(7), 1995]. Cell 81(4):641-650, 1995.
44. Cook HT, Bune AJ, Jansen AS, Taylor GM, Loi RK, Cattell V: Cellular localization of inducible nitric oxide synthase in experimental endotoxic shock in the rat. Clin Sci (Colch.) 87(2):179-186, 1994.
45. McMillan K, Adler M, Auld DS, Baldwin JJ, Blasko E, Browne LJ, Chelsky D, Davey D, Dolle RE, Eagen KA, Erickson S, Feldman RI, Glaser CB, Mallari C, Morrissey MM, Ohlmeyer MH, Pan G, Parkinson JF, Phillips GB, Polokoff MA, Sigal NH, Vergona R, Whitlow M, Young TA, Devlin JJ: Allosteric inhibitors of inducible nitric oxide synthase dimerization discovered via combinatorial chemistry. Proc Natl Acad Sci USA 97(4):1506-1511, 2000.
46. Digerness SB, Harris KD, Kirklin JW, Urthaler F, Viera L, Beckman JS, Darley-Usmar V: Peroxynitrite irreversibly decreases diastolic and systolic function in cardiac muscle. Free Radic Biol Med 27(11-12):1386-1392, 1999.
47. Loke KE, McConnell PI, Tuzman JM, Shesely EG, Smith CJ, Stackpole CJ, Thompson CI, Kaley G, Wolin MS, Hintze TH: Endogenous endothelial nitric oxide synthase-derived nitric oxide is a physiological regulator of myocardial oxygen consumption. Circ Res 84(7):840-845, 1999.
48. Sharma AC, Motew SJ, Farias S, Alden KJ, Bosmann HB, Law WR, Ferguson JL: Sepsis alters myocardial and plasma concentrations of endothelin and nitric oxide in rats. J Mol Cell Cardiol 29(5):1469-1477, 1997.
49. Alden KJ, Motew SJ, Sharma AC, Ferguson JL: Effect of aminoguanidine on plasma nitric oxide by-products and blood flow during chronic peritoneal sepsis. Shock 9(4):289-295, 1998.